Get the Stockscreener App
0.9696
1.06%
-0.0104
Pharmacyte Biotech Inc stock is traded at $0.9696, with a volume of 77,948.
It is down -1.06% in the last 24 hours and up +3.26% over the past month.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
See More
Previous Close:
$0.98
Open:
$0.99
24h Volume:
77,948
Relative Volume:
0.89
Market Cap:
$6.59M
Revenue:
-
Net Income/Loss:
$22.68M
P/E Ratio:
1.8294
EPS:
0.53
Net Cash Flow:
$-1.94M
1W Performance:
+1.51%
1M Performance:
+3.26%
6M Performance:
-22.43%
1Y Performance:
-49.24%
1-Day Range:
$0.9408
$0.99
1-Week Range:
$0.906
$1.18
52-Week Range:
$0.80
$2.4229
Pharmacyte Biotech Inc Stock (PMCB) Company Profile
Name
Pharmacyte Biotech Inc
Sector
Industry
Phone
(917) 595.2850
Address
3960 HOWARD HUGHES PARKWAY, LAS VEGAS
Compare PMCB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 2.24 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
4.34 | 6.18B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.12 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.825 | 133.49M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.2646 | 577.51M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.085 | 0 | 0 | 0 | 0 | 0.00 |
Pharmacyte Biotech Inc Stock (PMCB) Latest News
PharmaCyte Biotech Inc. recovery potential after sell offEarnings Beat & Risk Controlled Swing Trade Alerts - newser.com
Regression analysis insights on PharmaCyte Biotech Inc. performance2025 Year in Review & Real-Time Stock Price Movement Reports - newser.com
Intraday pattern recognizer results for PharmaCyte Biotech Inc.Trade Performance Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Is PharmaCyte Biotech Inc. stock bottoming outOptions Play & Community Consensus Picks - newser.com
Will PharmaCyte Biotech Inc. stock return to pre crisis levels2025 Key Lessons & Breakout Confirmation Alerts - newser.com
Relative strength of PharmaCyte Biotech Inc. in sector analysisGap Up & Smart Investment Allocation Insights - newser.com
PharmaCyte Biotech Inc. stock prediction for this weekJuly 2025 Patterns & AI Powered Market Entry Strategies - newser.com
Will PharmaCyte Biotech Inc. stock benefit from sector rotationJuly 2025 Spike Watch & Long-Term Safe Return Strategies - newser.com
Smart tools for monitoring PharmaCyte Biotech Inc.’s price actionJuly 2025 Reactions & High Accuracy Trade Signal Alerts - newser.com
What drives PharmaCyte Biotech Inc stock priceInstitutional Buying Trends & AI-Driven Stock Forecast Models - earlytimes.in
Published on: 2025-09-24 11:34:11 - newser.com
Published on: 2025-09-22 08:22:22 - newser.com
How to escape a deep drawdown in PharmaCyte Biotech Inc.Market Growth Review & Weekly Market Pulse Alerts - newser.com
Sentiment analysis tools applied to PharmaCyte Biotech Inc.2025 Institutional Moves & Fast Exit Strategy with Risk Control - newser.com
FOMO Trade: Should you buy the dip on PharmaCyte Biotech Inc2025 Price Action Summary & Fast Gain Swing Alerts - خودرو بانک
Earnings visualization tools for PharmaCyte Biotech Inc.Quarterly Portfolio Summary & Community Verified Watchlist Alerts - newser.com
Measuring PharmaCyte Biotech Inc.’s beta against major indicesWeekly Stock Report & AI Forecasted Entry/Exit Points - newser.com
Pharmacyte Biotech Inc Stock (PMCB) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.36%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):